LegoChem Biosciences Inc (141080) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of LegoChem Biosciences Inc stock KRW 37,490, price KRW 55,400, that is 32.3% below the price, quality 38 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
LegoChem Biosciences Inc
141080 · KQExpensive (fair value 32% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 17, 2026.
How to read this chart
60‑month range 30,650 KRW – 213,500 KRW · fair‑value band 28,118 KRW – 46,863 KRW · the 55,400 KRW price screens above the 37,490 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 17, 2026.
Every Wednesday you see whether LegoChem Biosciences is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
Show moreShow less
The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies.
It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was formerly known as LegoChem Biosciences, Inc. and changed its name to LigaChem Biosciences Inc. in April 2024.
LigaChem Biosciences Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.
Stock analysis
LegoChem Biosciences Inc (141080) currently trades at 55,400 KRW, while our estimate is 37,490 KRW, 32% below the price, so the stock looks overvalued today.
Show more
Valuation
None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.
Scenario range: 28,118 KRW (bear) to 46,863 KRW (bull), the price of 55,400 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 38/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
LegoChem Biosciences Inc reported revenue of 142B KRW in FY2025 versus 32.2B KRW in FY2021, a compound +44.8%/yr. Reported net income was −74.3B KRW in FY2025.
Key figures
Market cap 2.5T KRW (≈ $1.8B) Small · P/S ratio 24.9 · EPS (TTM) −4,517 KRW · Net margin −52.5% · Return on equity −36.6% · Return on assets (EBIT) −18.0% (5-year average) · Operating margin −208% · Revenue (TTM) 98.8B KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).
What moves the price
The share trades about 74% below its 52-week high and at its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −7% fair-value upside, at −32%, 141080 screens richer than that median.
Fair Value
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Compare LegoChem Biosciences Inc with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Biotechnology · 848 stocks
Valuation Multiplesvs Biotechnology median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Net margin by industry
- P/B ratio by industry
- PEG screener for stocks with fair value
- Undervalued stocks: South Korean Stocks
- Valuation of the Korea market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Biotechnology stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Regeneron Pharmaceuticals, Inc REGN | $952.40 | $1,275 | +34% | vs 141080 |
| Vertex Pharmaceuticals Incorporated VRTX | $537.79 | $592.46 | +10% | vs 141080 |
| Samsung Biologics Co 207940 | 1,423,000 KRW | 1,552,100 KRW | +9% | vs 141080 |
| argenx SE ARGX | $950.95 | $908.40 | −4% | vs 141080 |
| CSL Limited CSL | A$199.55 | A$186.49 | −7% | vs 141080 |
| Moderna, Inc MRNA | $215.27 | $135.64 | −37% | vs 141080 |
| BeOne Medicines AG 6160 | HK$249.40 | HK$152.92 | −39% | vs 141080 |
| Revolution Medicines, Inc RVMD | $166.87 | $88.78 | −47% | vs 141080 |
| Celltrion, Inc 068270 | 214,500 KRW | 74,945 KRW | −65% | vs 141080 |
| Royalty Pharma plc RPRX | $68.53 | $19.01 | −72% | vs 141080 |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is LegoChem Biosciences Inc (141080) overvalued or undervalued?
What is the fair value of 141080?
What is the quality score of 141080?
What is the price target for LegoChem Biosciences Inc (141080)?
What is the LegoChem Biosciences Inc stock forecast for 2026?
What is the revenue of LegoChem Biosciences Inc (141080)?
What is the intrinsic value of LegoChem Biosciences Inc (141080)?
Is LegoChem Biosciences Inc stock overvalued or undervalued in 2026?
Is fair value the same as the market price of 141080?
How much is LegoChem Biosciences Inc worth?
What do the bullish and bearish scenarios say about 141080?
How solid is the balance sheet of LegoChem Biosciences Inc (141080)?
How far is 141080 from its 52-week high?
Which stocks are comparable to LegoChem Biosciences Inc?
Is LegoChem Biosciences Inc stock attractive at the current price?
Is it still worth investing in stocks now?
What is the share price of LegoChem Biosciences Inc (141080)?
What should I pay attention to with LegoChem Biosciences Inc right now?
Key figures of LegoChem Biosciences Inc
How large is the market capitalisation of LegoChem Biosciences Inc (141080)?
What is the P/S ratio of LegoChem Biosciences Inc (141080)?
What are the earnings per share of LegoChem Biosciences Inc (141080)?
What is the net margin of LegoChem Biosciences Inc (141080)?
What is the return on equity of LegoChem Biosciences Inc (141080)?
What is the EBIT return on assets of LegoChem Biosciences Inc (141080)?
What is the operating margin of LegoChem Biosciences Inc (141080)?
How fast is revenue growing at LegoChem Biosciences Inc (141080)?
How fast are earnings growing at LegoChem Biosciences Inc (141080)?
How much free cash flow does LegoChem Biosciences Inc (141080) generate?
Watch LegoChem Biosciences Inc in the live analysis
One click puts LegoChem Biosciences Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.